|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4184 | |
| A61K 31/4188 | |||
| A61K 31/435 | |||
| C07D 487/04 | |||
| C07D 413/04 | |||
| C07D 471/04 | |||
| C07D 473/34 | |||
| A61P 35/00 |
| (11) | Number of the document | 3010503 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14820520.6 |
| Date of filing the European patent application | 2014-06-20 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/043423 |
| Date | 2014-06-20 |
| (87) | Number | WO 2015/002754 |
| Date | 2015-01-08 |
| (30) | Number | Date | Country code |
| 201361837841 P | 2013-06-21 | US |
| (72) |
DUFFY, Bryan, Cordell, US
LIU, Shuang, US
QUINN, John, Frederick, US
WANG, Ruifang, US
JIANG, May, Xiaowu, US
MARTIN, Gregory, Scott, US
WAGNER, Gregory, Steven, US
YOUNG, Peter, Ronald, US
|
| (73) |
Zenith Epigenetics Ltd.,
300, 4820 Richard Road SW, Calgary, AB T3E 6L1,
CA
|
| (54) | NOVEL BICYCLIC BROMODOMAIN INHIBITORS |
| NOVEL BICYCLIC BROMODOMAIN INHIBITORS |